GAMMA Investing »

Biodexa Pharmaceuticals shares owned by GAMMA Investing

Quarter-by-quarter ownership of Biodexa Pharmaceuticals (BDRX) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Biodexa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biodexa Pharmaceuticals held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodexa Pharmaceuticals by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.0k 1.8k 2.27
2025-09-30 $9.0k 1.4k 6.65

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Tesla Common Stock (TSLA)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Ishares Tr National Mun Etf Etf (MUB)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Visa Inc Com Cl A Common Stock (V)

View all positions for GAMMA Investing

Top funds holding Biodexa Pharmaceuticals

Sabby Management
Hrt Financial
UBS Group
GAMMA Investing
SBI Securities
Rhumbline Advisers

View all funds holding Biodexa Pharmaceuticals